Home
Lucius Bader's picture

Lucius Bader

PhD Candidate
  • E-mailLucius.Bader@uib.no
  • Phone+47 +4775382
  • Visitor Address
    Haukeland universitetssykehus, Laboratoriebygget
  • Postal Address
    Postboks 7804
    5020 Bergen
Academic article
  • 2019. Titrating complex mass cytometry panels. Cytometry Part A. 1-6.
  • 2019. Optimization of receptor occupancy assays in mass cytometry: Standardization across channels with QSC beads. Cytometry Part A. 314-222.
  • 2019. Candidate markers for stratification and classification in rheumatoid arthritis. Frontiers in Immunology. 1-8.
  • 2018. Phosphorylation of intracellular signaling molecules in peripheral blood cells from psoriasis patients on originator or biosimilar infliximab. British Journal of Dermatology. 371-380.
  • 2017. Assays for Infliximab Drug Levels and Antibodies: A Matter of Scales and Categories. Scandinavian Journal of Immunology. 165-170.
  • 2016. Signaling effects of sodium hydrosulfide in healthy donor peripheral blood mononuclear cells. Pharmacological Research. 216-227.
  • 2013. Sustained hypogammaglobulinemia under rituximab maintenance therapy could increase the risk for serious infections: a report of two cases. Rheumatology International. 1643-1644.
  • 2011. Sustained hypogammaglobulinemia under rituximab maintenance could increase the risk for serious infections: a report of two cases. Rheumatology International.
  • 2010. B-lymphocyte activating factor levels are increased in patients with Wegener's granulomatosis and inversely correlated with ANCA titer. Clinical Rheumatology. 1031-1035.
Abstract
  • 2012. If remission and low disease activity is the treatment goal in rheumatoid arthritis, how far are we from this goal in patients currently treated with biologics in ordinary clinical practice? Data from the Norwegian BIORHEUMA project. Scandinavian Journal of Rheumatology. 58-58.
  • 2012. If remission and low disease activity is the treatment goal in RA. How far are we from thos goal in patietns currently treated with biologics in ordinary clinical practice? Data from the Norwegian BIORHEUMA prosjekt. Annals of the Rheumatic Diseases. 713.
  • 2012. If remission and low disease activity is the treatment goal in RA, How far are we from thos goal in patietns currently treated with biologics in ordinary clinical practice? Data from the Norwegian BIORHEUMA project. Annals of the Rheumatic Diseases. 713.
  • 2012. Current and previous use of biologics in rheumatoid arthritis patients: data from the Norwegian BIORHEUMA project. Scandinavian Journal of Rheumatology. 58-59.
  • 2010. A 4-YEAR PROSPECTIVE SINGLE-CENTER STUDY ON RITUXIMAB TREATMENT IN REFRACTORY ANCA ASSOCIATED VASCULITIS. Scandinavian Journal of Rheumatology. 36-36.
Poster
  • 2018. Diagnosing rheumatoid arthritis with mass cytometry using topological data analysis.

More information in national current research information system (CRIStin)